Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

by Cyrus Huneycutt | Sep 1, 2025 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.